Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer

NICE technology appraisals [TA112] Published date:

Anastrozole, exemestane and letrozole are recommended as possible treatments for women who have a type of breast cancer called early oestrogen-receptor-positive breast cancer and have been through the menopause. Anastrozole, exemestane or letrozole may be given as an 'extra' treatment (called an adjuvant treatment), after the woman has had an operation to remove the cancer, to help to stop the cancer coming back.

Get involved